Navigation Links
Dendreon Corp. (Nasdaq: DNDN) - Prostate Cancer Patients Benefit
Date:4/30/2009

VALLEY COTTAGE, N.Y., April 30 /PRNewswire/ -- Less than two weeks ago, early on April 15th, Stock Preacher, in their Stock Talk section, posted a Special Technical Report on Dendreon Corporation (Nasdaq: DNDN), which we have been watching since 2007, when we first learned about it.

On April 14, DNDN gapped open on positive news from the previous day's close of 7.30/shr, to 16.00/shr, ran to 22.00/shr and closed at 16.99/shr + 9.69 (132%) on 65,345,600/shrs on the day, and since has traded as high as 27.00/shr over the past several trading sessions. From a technical POV, DNDN has traded down to close the gap it posted on the opening on April 14. This is very positive and Bullish action.

When we go back to look at the Stock Talk coverage, the Red Roadmaster's analysis after the April 14, 2009 market action was overall Bullish: in the near term Very Bullish, mid-term Bullish, and long term Bullish.

That analysis has proven to be true and the shares are having a dramatic run here, with overhead resistance Nil, and strong underlying support 21.40.

Yesterday,(April 29, 2009) DNDN closed + 11.13/shr (95%) at 23.00 on 48,134,768/shrs., the high on the day was 27.00/.

Late Tuesday afternoon, the Company released data from a Phase III clinical study that showed Provenge extended the lives of men with advanced prostate cancer by an average of 4.1 months. According to published analysts, Dendreon should be able to file for regulatory approval during the Q-4 Y 2009, with possible approval during the first half of 2010.

This is Dendreon Corp (DNDN): Dendreon is developing therapeutic vaccines that boost the body's immune system to help it fight cancer by targeting dendritic cells, which initiate an immune response to disease-causing antigens. Its lead candidate is Provenge, a therapeutic vaccine that targets prostate cancer. Dendreon is also working on a therapeutic vaccine called Neuvenge as a treatment for breast, colon, ovarian, and kidney cancers; and it has research programs investigating cancer-fighting monoclonal antibodies and small molecule drugs. Its partners for its antibody programs include Amgen and Genentech

For more updates on Dendreon Corp (Nasdaq: DNDN), and other Companies making news, visit us at http://StockPreacher.com

StockPreacher.com Disclosure

StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a wholly owned entity of Allan James Group, Inc., a financial public relations firm. Please read our report and visit our website, StockPreacher.com, for complete risks and disclosures.

Investors can view all of the daily updates for free by visiting: http://StockPreacher.com/

Julio Serrano of Stock Preacher is a member of the National Association of Securities Dealers, CRD number 1603068.


'/>"/>
SOURCE Stock Preacher
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. -Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET-
2. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
3. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
4. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
5. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
6. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
7. New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets
8. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
9. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
10. Former State Representative Terry Parke Joins Secure Services Corp.
11. InstaCare Corp. Reviewing M&A Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: